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Tumour tissue develops an inadequate vasculature and an
abnormal physiological microenvironment during growth (Vaupel
et al, 1989). Angiogenesis, i.e. the process of generation and
development of capillary blood vessels, is necessary for a tumour
to grow beyond a certain size given by the diffusion distances of
oxygen and other nutrients (Folkman, 1990). The rate of angio-
genesis is usually not sufficiently high to keep up with the rate of
proliferation of the malignant tumour cells (Denekamp and
Hobson, 1982). The capillary network of tumours therefore shows
characteristic architectural and functional abnormalities, which
result in insufficient oxygen supply and the development of
regions of hypoxic tissue (Coleman, 1988; Vaupel et al, 1989).
Two types of hypoxia have been recognized in tumours: chronic
hypoxia, arising from limitations in oxygen diffusion, and acute
hypoxia, resulting from transient stoppages in microregional blood
flow (Horsman, 1995). Chronically hypoxic cells usually lie
remotely from capillaries, whereas acutely hypoxic cells can be
found adjacent to capillaries (Coleman, 1988; Horsman, 1995).
Metastasis, i.e. the spread of malignant tumour cells from the
primary neoplasm to distant sites, is influenced by the angiogenic
potential and the oxygenation status of the tumour cells (Hill,
1990; Weidner, 1993).
The relationship between tumour metastasis and angiogenesis
has been demonstrated in a series of clinical studies involving a
wide range of histological types of tumours (Weidner et al, 1991;
Macchiarini et al, 1992; Gasparini et al, 1993; Bochner et al,
1995). These studies showed that the probability of metastasis is
positively correlated to the vascular density of the primary tumour
and led to the suggestion that vascular density might be an inde-
pendent prognostic indicator in malignant diseases (Weidner,
1993). The metastatic propensity of a tumour might be influenced
by the angiogenic potential of the tumour cells by two independent
mechanisms: high vascular density in the primary tumour might
enhance the opportunity of the tumour cells to gain access to the
blood stream and elevated capacity to induce neovascularization
might increase the probability of tumour cells trapped in distant
organ capillary beds to give rise to macroscopic tumour growth
(Fidler and Ellis, 1994).
Significant correlations between tumour metastasis and
oxygenation or between tumour metastasis and lactate concentra-
tion have been demonstrated in clinical studies involving soft
tissue sarcoma (Brizel et al, 1996), cervix carcinoma (Schwickert
et al, 1995; Höckel et al, 1996; Sundfør et al, 1998) and carcinoma
of the head and neck (Walenta et al, 1997). High lactate concentra-
tion is indicative of extensive anaerobic metabolism and hence
poor oxygenation in tumour tissue (Vaupel et al, 1989). These
studies are apparently inconsistent with those showing correlations
between tumour metastasis and angiogenesis as primary tumours
with low oxygen tensions or high lactate concentrations were
found to metastasize more frequently than primary tumours with
high oxygen tensions or low lactate concentrations (Schwickert
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Summary Tumour cells exposed to hypoxia have been shown to up-regulate the expression of vascular endothelial growth factor (VEGF).
The purpose of the present work was to investigate whether hypoxia-induced VEGF up-regulation can result in increased metastatic
efficiency of human melanoma cells. Two melanoma lines, one showing high (A-07) and the other showing low (D-12) VEGF secretion under
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the other hand showed unchanged metastatic efficiency, transplantability and angiogenic potential following exposure to hypoxia. Both cell
lines showed significantly decreased metastatic efficiency and angiogenic potential in mice treated with neutralizing antibody against VEGF.
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1997; Sundfør et al, 1998). However, they are consistent with a
study of experimental murine tumours which showed that tumour
cells exposed to transient hypoxia in vitro are more metastatic
than aerobic control cells when injected intravenously (i.v.) in
syngeneic mice (Young et al, 1988).
Tumour cells exposed to hypoxia in vitro or in vivo show
increased expression of several selected genes, including the gene
encoding vascular endothelial growth factor (VEGF) (Dachs and
Stratford, 1996). VEGF is a potent angiogenic factor existing in
four different isoforms (VEGF121,165,189,206) arising from alternative
m-RNA splicing (Zagzag, 1995). The expression of VEGF is
correlated to vascular density in several histological types of
human tumours (Guidi et al, 1995; Toi et al, 1995; Takahashi et al,
1995; Mattern et al, 1996). Xenografted tumours established from
cell lines transfected with VEGF show increased vascular density,
volumetric growth rate and metastatic frequency relative to wild-
type control tumours (Zhang et al, 1995; Claffey et al, 1996;
Pötgens et al, 1996), whereas xenografted tumours initiated from
cell lines transfected with antisense-VEGF c-DNA show reduced
vascular density and growth (Saleh et al, 1996). The neovascular-
ization of experimental tumours is inhibited by treatment with
monoclonal antibodies against VEGF (Kim et al, 1993; Asano
et al, 1995; Melnyk et al, 1996).
The possibility thus exists that hypoxic tumour cells after
dissemination have increased capacity to induce neovasculariza-
tion in secondary organ sites and hence are more metastatic than
their normoxic counterparts, owing to increased VEGF expression
induced by the hypoxic microenvironment. The purpose of the
work reported here was to test this hypothesis. Cells from two
human melanoma lines differing significantly in VEGF synthesis
and secretion were exposed to hypoxia in vitro. Metastatic
efficiency, i.e. lung colonization efficiency, was assessed in
athymic nude mice after i.v. administration of tumour cells.
Transplantability and angiogenic potential were also determined in
vivo, using intradermal (i.d.) assays in athymic nude mice.
Hypoxia-induced VEGF up-regulation was studied in vitro using
Western blot analysis and ELISA.
MATERIALS AND METHODS
Mice
Adult (8–10 weeks old) female BALB/c-nu/nu mice were used
as host animals to assess tumour cell metastatic efficiency, trans-
plantability and angiogenic potential. The mice were bred at our
institute and maintained under specific pathogen-free conditions
at constant temperature (24–26°C) and humidity (30–50%).
Sterilized food and tap water were given ad libitum.
Cell lines
Two human melanoma cell lines (A-07 and D-12) giving rise to
pulmonary metastases in athymic nude mice were included in
the study (Rofstad, 1994). The cell lines were maintained in
monolayer culture in RPMI-1640 medium (25 mM HEPES and
L-glutamine) supplemented with 13% fetal calf serum, 250 mg l–1
penicillin and 50 mg l–1 streptomycin. The cultures were incubated
at 37°C in a humidified atmosphere of 5% carbon dioxide in air
and subcultured twice a week by trypsinization (treatment with
0.05% trypsin–0.02% EDTA solution at 37°C for 2 min). The cell
lines were verified to be free from Mycoplasma contamination by
using the Hoechst fluorescence and the mycotrin methods.
Hypoxia exposure
Monolayer cell cultures growing in glass dishes were exposed to
hypoxia for 0–24 h by using the steel-chamber method (Sanna and
Rofstad, 1994). The cultures were incubated at 37°C in a humidi-
fied atmosphere of 5% carbon dioxide in air for 24 h before the
hypoxia treatment. The culture medium was removed and replaced
by fresh medium immediately before the cells were exposed to
hypoxia. The medium used during the hypoxia treatment was
supplemented with 2.2 g l–1 sodium bicarbonate. The pH of the
medium was 7.4 ± 0.1. The glass dishes were kept in air-tight steel
chambers during the hypoxia treatment. The medium layer
covering the cells was approximately 2 mm in thickness. The steel
chambers were flushed with a humidified, highly purified gas
mixture consisting of 95% nitrogen and 5% carbon dioxide at a
flow rate of 5 l min–1. Measurements showed that the concentra-
tion of oxygen in the medium was less than 10 ppm after 30 min of
flushing. Control cultures were flushed with humidified 5%
carbon dioxide in air. The cells were reoxygenated by opening the
steel-chambers. The cultures were kept in fresh medium in
humidified 5% carbon dioxide in air for reoxygenation times of
0–24 h before the cells were detached from the glass dishes by
trypsinization and washed in Ca2+- and Mg2+-free Hanks’ balanced
salt solution (HBSS). Cell aggregates were not seen in any of the
suspensions.
Cell viability assay
The viability of cells from control and hypoxia-treated cultures
was assessed by measuring plating efficiency (PE) in vitro
(Rofstad, 1992). Aliquots of 2.0 ´ 102 cells suspended in 1 ml of
fresh medium were plated in 25-cm2 culture flasks. The flasks
contained approximately 1.0 ´ 105 lethally irradiated (30 Gy)
feeder cells in 4 ml of medium, plated 24 h earlier. The cells were
incubated at 37°C in a humidified atmosphere of 5% carbon
dioxide in air for 10 days. The medium was removed and replaced
by fresh medium on day 7. The cells were fixed in 100% ethanol
and stained with methylene blue. Colonies containing more than
50 cells were counted using a stereomicroscope.
Metastasis assay
Metastatic efficiency was assessed by using a lung colonization
assay (Rofstad, 1995). Aliquots of 2.0 ´ 106–3.0 ´ 106 A-07 cells
or 5.0 ´ 105 D-12 cells suspended in 0.2 ml of HBSS were
inoculated into the lateral tail vein of mice by using a tuberculin
syringe with a 26-gauge needle. The mice were killed and
autopsied 5 weeks after the inoculation. The lungs were removed,
rinsed in HBSS and fixed in Bouin’s solution for 24 h to facilitate
the scoring of colonies. The number of surface colonies was
recorded using a stereomicroscope. Metastatic efficiency in terms
of number of lung colonies per 1.0 ´ 106 viable A-07 cells or per
1.0 ´ 105 viable D-12 cells was determined by correcting the
number of colonies for the number of cells per inoculum and the
PE measured in vitro, as recommended by Young et al (1988).
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Transplantability was assessed using an intradermal transplanta-
tion assay (Rofstad, 1995). A 100-ml Hamilton syringe was used to
inoculate aliquots of 10 ml of cell suspension into the flank of
mice. The cells were suspended in HBSS, and the number of cells
per inoculum was varied within the ranges 2.0 ´ 103–2.0 ´ 105
(A-07) and 2.0 ´ 102–5.0 ´ 104 (D-12). The inoculation point lay
above the subcutaneous muscle tissue in the deeper part of the
dermis. The mice were examined twice weekly for up to 120 days
after the inoculation. A transplantation was scored as positive
when the tumour diameters reached 10–12 mm, and then the host
was killed. All positive transplantations were scored before day 90
after the inoculation. The fraction of positive transplantations was
plotted vs the number of cells per inoculum, and probit regression
lines were fitted to the data.
Angiogenesis assay
Angiogenic potential was assessed using an i.d. angiogenesis assay
(Kreisle and Ershler, 1988). Aliquots of 10 ml of cell suspension
were inoculated i.d. in mice, using the same procedure as used in
the transplantability studies described above. The number of cells
per inoculum was varied within the range 2.5 ´ 104–1.3 ´ 106.
The mice were killed on day 5 (A-07) or day 7 (D-12) after
the inoculation. Small vascularized tumours had developed in the
inoculation sites at that time. The skin around the inoculation
sites was removed and the tumours were located with a dissecting
microscope. Angiogenesis was quantified by counting the capil-
laries in the dermis oriented towards the tumours (Rofstad, 1994).
The number of capillaries was corrected for the background, deter-
mined after the injection of 10 ml HBSS. The tumours were
dissected free from the skin and weighed after the tumour-oriented
capillaries had been scored. The number of capillaries was plotted
versus the number of cells per inoculum, and linear regression
lines were fitted to the data.
Treatment with anti-VEGF neutralizing antibody
The specific role of VEGF in metastasis and angiogenesis was
investigated by assessing metastatic efficiency and angiogenic
potential in mice treated with the anti-human VEGF neutralizing
monoclonal antibody MAB293 (R&D Systems, Inc., Minneapolis,
MN, USA). This antibody is produced from a murine hybridoma
elicited from a mouse immunized with purified insect cell line Sf
21-derived recombinant human VEGF. The antibody does not
cross-react with human platelet derived growth factor. Two doses
of MAB293 of 25 mg in 0.2 ml of phosphate-buffered saline (PBS)
were administered to the mice by intraperitoneal (i.p.) injection.
The first dose was given 1 h before and the second dose 23 h after
tumour cells were inoculated either into the lateral tail vein for
formation of lung colonies or i.d. for evocation of angiogenesis
and tumour formation.
Western blot analysis of intracellular VEGF
Cells were washed in PBS and boiled in Laemmli sample buffer
for 5 min (Laemmli, 1970). Proteins were separated by electro-
phoresis in 13% sodium dodecyl sulphate-polyacrylamide gels and
blotted to polyvinylidene difluoride transfer membranes (Towbin
et al, 1979). Membranes were incubated with the A-20 anti-VEGF
rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA) for 60 min. Bound antibody was
detected using a biotin–streptavidin alkaline phosphatase staining
procedure.
ELISA analysis of VEGF secretion
VEGF concentration in culture medium was measured using a
commercially available human VEGF165 enzyme-linked immuno-
sorbent assay (ELISA) kit (R&D Systems, Inc., Minneapolis, MN,
USA) according to manufacturer’s instructions. Medium samples
were collected from cell cultures immediately before and after a
24-h hypoxia treatment, centrifuged to remove particulates, and
assayed in duplicate. Absorbances were read at 450 nm. Readings
at 570 nm were subtracted from the readings at 450 nm to correct
for optical imperfections in the plates. Rate of VEGF secretion
(Rsec) was calculated as
where DC is the increase in VEGF concentration during the time
interval Dt (24 h), Ni and Nf are the initial and final cell numbers
and V is the volume of medium. The second factor of this product
is based on the assumption that the cell number increased expo-
nentially with time during Dt, an assumption which was verified to
be fulfilled for aerobic control cultures. There was no cell prolifer-
ation under hypoxic conditions, i.e. the second factor of the
product was ~ 1 for hypoxic cultures. Replicate cultures were used
to determine Ni. Cell numbers were counted using a haemo-
cytometer. The fraction of Trypan-blue-excluding cells after
treatment was > 95% and similar for control and hypoxia-treated
cultures.
Statistical analysis
Results are presented as arithmetic mean ± s.e.m. Statistical
comparisons of mean values were performed under conditions of
normality and equal variance by using the Student’s t-test for
single comparisons and one-way analysis of variance (ANOVA)
and the Student–Newman–Keuls test for multiple comparisons.
All P-values were determined from two-sided tests. Probability
values of P < 0.05 were considered significant. The statistical
analysis was performed using SigmaStat statistical software
(Jandel Scientific GmbH, Erkrath, Germany).
RESULTS
Exposure to hypoxia resulted in a transient increase in the
metastatic efficiency of the D-12 cells (Figure 1). The metastatic
efficiency was highest immediately after the reoxygenation. It
increased with the duration of the hypoxia treatment and decreased
with the reoxygenation time. A hypoxia treatment of 4 h was
sufficient to increase the metastatic efficiency significantly. Thus,
the metastatic efficiency of cell cultures exposed to hypoxia for
4 h was significantly higher than that of aerobic control cultures,
whether the hypoxia-treated cultures were assayed immediately
(< 1 h) after (P < 0.01) or 4 h after (P < 0.05) the reoxygenation.
The maximum increase in metastatic efficiency was most likely
reached after a hypoxia treatment of 16–24 h. Cell cultures
exposed to hypoxia for 24 h and assayed immediately after or
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VDC ´ 1n(Nf/Ni)
Rsec = NiDt( N f /Ni – 1)4 h after the reoxygenation showed a metastatic efficiency which
was higher than that of aerobic control cultures by factors of 3–4
(P < 0.005) and 2–3 (P < 0.01) respectively. A reoxygenation time
of 24 h was sufficient to eliminate the hypoxia-induced increase in
metastatic efficiency. Thus, the metastatic efficiency of cell
cultures exposed to hypoxia for 24 h and assayed 24 h after the
reoxygenation was not significantly different from that of aerobic
control cultures (P > 0.05). In contrast, exposure to hypoxia did
not change the metastatic efficiency of the A-07 cells (Figure 1);
cell cultures exposed to hypoxia for 4, 8, 16 or 24 h and assayed
immediately after, 4 h after or 24 h after the reoxygenation showed
a metastatic efficiency which was not significantly different from
that of aerobic control cultures (P > 0.05). The metastasis data
presented in Figure 1 were calculated by taking into consideration
the PE in vitro of the cell cultures (Table 1). The PE values of cell
cultures treated equally were not significantly different for A-07
and D-12 cells (P > 0.05; Figure 2).
The transplantability of the D-12 cells also increased transiently
by exposure to hypoxia, independent of the number of cells per
inoculum (Figure 3). It was highest immediately after the reoxy-
genation and decreased with the reoxygenation time, similar to the
metastatic efficiency. Thus, the transplantability of cell cultures
exposed to hypoxia for 24 h was significantly higher than that of
aerobic control cultures when the hypoxia-treated cultures were
assayed immediately after (P < 0.005) or 4 h after the reoxygena-
tion (P < 0.01). Moreover, the cell cultures assayed immediately
after the reoxygenation showed a significantly higher trans-
plantability than the cell cultures assayed 4 h after the reoxygena-
tion (P < 0.01). A reoxygenation time of 24 h was sufficient to
eliminate the hypoxia-induced increase in transplantability; cell
cultures assayed 24 h after the reoxygenation showed a trans-
plantability which was not significantly different from that of
aerobic control cultures (P > 0.05; data not shown). In contrast,
exposure to hypoxia did not change the transplantability of the
A-07 cells (Figure 3); the transplantability of cell cultures exposed
to hypoxia for 24 h and assayed immediately after or 4 h after the
reoxygenation was not significantly different from that of aerobic
control cultures (P > 0.05).
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Figure 1 A-07 (A) and D-12 (B) cells were exposed to hypoxia in vitro,
reoxygenated and inoculated intravenously in female BALB/c-nu/nu mice for
formation of lung colonies. The lung colonies were scored 5 weeks after the
inoculation. The plots show number of lung colonies per 1.0 ´ 106 viable A-07
cells or per 1.0 ´ 105 viable D-12 cells vs time under hypoxic conditions. The
cells were inoculated immediately (< 1 h) after the reoxygenation (n),
4 h after the reoxygenation (D) or 24 h after the reoxygenation (•). Mean
values (points) and s.e.m. (bars) of 6–10 experiments, each involving
10 mice. The hatched horisontal bars refer to aerobic control cultures
(mean values ± s.e.m.)
Figure 2 A-07 (A) and D-12 (B) cells were exposed to hypoxia in vitro,
reoxygenated and plated in tissue culture flasks for colony formation. The
colonies were scored 10 days after the plating. The plots show PE vs time
under hypoxic conditions. The cells were plated immediately (< 1 h) after the
reoxygenation (n), 4 h after the reoxygenation (D) or 24 h after the
reoxygenation (•). Mean values (points) and s.e.m. (bars) of 6–10
experiments. The hatched horisontal bars refer to aerobic control cultures
(mean values ± s.e.m.)Hypoxia treatment also increased transiently the angiogenic
potential of the D-12 cells (Figure 4). The magnitude of the
increase was independent of the number of cells per inoculum. The
kinetics were similar to the kinetics of the transient increases in
metastatic efficiency and transplantability. Thus, after a hypoxia
treatment of 24 h, the angiogenic potential was significantly higher
for cell cultures assayed immediately after the reoxygenation than
for cell cultures assayed 4 h after the reoxygenation (P < 0.01),
which in turn showed a significantly higher angiogenic potential
than aerobic control cultures (P < 0.01). The hypoxia-induced
increase in angiogenic potential was eliminated 24 h after the
reoxygenation; the angiogenic potential of cell cultures assayed
24 h after the reoxygenation did not differ significantly from that
of aerobic control cultures (P > 0.05; data not shown). In contrast,
Hypoxia-induced metastasis and VEGF 1701
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Table 1 Data regarding the assessment of metastatic efficiency of A-07 and D-12 cells
Time between
Duration of hypoxia treatment (h)
reoxygenation and
A-07 D-12
cell inoculation (h) 0 4 8 16 24 0 4 8 16 24
Number of cells per inoculum
0 2.0 ´ 106 2.0 ´ 106 2.0 ´ 106 3.0 ´ 106 3.0 ´ 106 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105
4 2.0 ´ 106 2.0 ´ 106 2.0 ´ 106 3.0 ´ 106 3.0 ´ 106 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105
24 2.0 ´ 106 2.0 ´ 106 2.0 ´ 106 3.0 ´ 106 3.0 ´ 106 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105 5.0 ´ 105
Number of lung colonies
0 19 ± 6a 17 ± 4 16 ± 4 20 ± 49   ± 4 41 ± 8 69 ± 13 91 ± 15 79 ± 12 44 ± 5
4 21 ± 4 22 ± 5 21 ± 4 14 ± 7 12 ± 5 40 ± 6 59 ± 10 64 ± 11 49 ± 8 29 ± 5
24 17 ± 5 21 ± 5 17 ± 6 19 ± 9 25 ± 7 38 ± 8 31 ± 8 48 ± 5 26 ± 7 28 ± 6
Plating efficiency in vitro (%)
0 80 ± 4b 77 ± 6 72 ± 7 45 ± 8 26 ± 9 78 ± 6 75 ± 7 70 ± 8 48 ± 8 25 ± 10
4 77 ± 6 74 ± 6 72 ± 6 53 ± 8 29 ± 10 80 ± 5 76 ± 6 73 ± 6 45 ± 8 28 ± 8
24 79 ± 5 82 ± 7 74 ± 6 63 ± 8 57 ± 8 78 ± 5 74 ± 6 75 ± 6 67 ± 8 54 ± 9
Metastatic efficiency, i.e. number of lung colonies per 1 ´ 106 viable A-07 cells or per 1.0 ´ 105 viable D-12 cells
0 12 ± 4 10 ± 3 13 ± 3 14 ± 31 1   ± 49   ± 2 20 ± 4 26 ± 6 32 ± 7 35 ± 6
4 13 ± 3 14 ± 4 15 ± 3 10 ± 5 14 ± 49   ± 1 16 ± 3 18 ± 4 22 ± 5 22 ± 5
24 12 ± 4 13 ± 4 10 ± 51 1   ± 5 15 ± 5 10 ± 39   ± 3 12 ± 28   ± 3 10 ± 3
aMean ± s.e.m. of 6–10 experiments, each involving 10 mice, i.e. the value derived from each experiment was the mean number of colonies of 10 pairs of lungs.
bMean ± s.e.m. of 6–10 experiments, each involving 4 culture flasks, i.e. the value derived from each experiment was the mean number of colonies of 4 flasks.
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Figure 3 A-07 (A) and D-12 (B) cells were exposed to hypoxia in vitro, reoxygenated and inoculated intradermally in female BALB/c-nu/nu mice for tumour
formation. The mice were examined for up to 120 days after the inoculation. The plots show percentage of positive transplantations vs number of cells per
inoculum. The cells were harvested from aerobic control cultures (•) or cultures exposed to hypoxia for 24 h (n, D). The hypoxia-treated cells were inoculated
immediately (< 1 h) after the reoxygenation (n) or 4 h after the reoxygenation (D). Points are based on 20–30 inoculations. Probit regression lines were fitted
to the datathe angiogenic potential of the A-07 cells was not changed by
hypoxia treatment (Figure 4); cell cultures exposed to hypoxia for
24 h and assayed immediately after or 4 h after the reoxygenation
showed an angiogenic potential which was not significantly
different from that of aerobic control cultures (P > 0.05). There
was a strong correlation between tumour weight and number of
tumour-oriented capillaries for each cell line (P < 0.0001; data
not shown).
Western blot analysis showed that the concentration of intracel-
lular VEGF protein was similar in A-07 and D-12 cells (Figure 5).
Three bands were detected, possibly corresponding to glyco-
sylated VEGF165, non-glycosylated VEGF165 and VEGF121. If so,
non-glycosylated VEGF165 and VEGF121 were up-regulated in cell
cultures exposed to hypoxia for about 4 h and 24 h, respectively.
In contrast, the rate of VEGF secretion differed between the cell
lines (Figure 6). The A-07 cells showed a higher secretion rate
than the D-12 cells, both under aerobic (P < 0.005) and hypoxic
(P < 0.01) conditions. The secretion rate was higher for hypoxic
cultures than for aerobic cultures by factors of approximately
1.5 (A-07; P < 0.05) and 7 (D-12; P < 0.001). The absolute
increase in VEGF secretion rate was higher for the A-07 cells than
for the D-12 cells (P < 0.05; Figure 6). Consequently, the D-12
cells, which showed significant hypoxia-induced increases in
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Figure 4 A-07 (A) and D-12 (B) cells were exposed to hypoxia in vitro, reoxygenated and inoculated intradermally in female BALB/c-nu/nu mice for
angiogenesis evocation and tumour formation. Angiogenesis was quantified by counting the capillaries in the dermis oriented towards the tumours at day 5
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Figure 5 Western blots representing the intracellular VEGF concentration in
A-07 and D-12 cells grown in monolayer culture under hypoxic conditions for
0 (aerobic control cultures), 4, 8 or 24 h. Proteins from 5.0 ´ 105 cells were
loaded into each lane. Three bands are seen, possibly corresponding to
glycosylated VEGF165, nonglycosylated VEGF165 and VEGF121
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Figure 6 Rate of VEGF secretion in A-07 and D-12 cells grown in
monolayer culture under aerobic or hypoxic conditions. Mean values
(columns) and s.e.m. (bars) of 3–7 experimentsmetastatic efficiency, transplantability and angiogenic potential,
had a lower VEGF secretion rate under aerobic conditions and a
lower hypoxia-induced increase in the VEGF secretion rate than
the A-07 cells, which did not show significant hypoxia-induced
increases in metastatic efficiency, transplantability and angiogenic
potential.
Treatment of host mice with neutralizing antibody against
VEGF resulted in a decrease in the metastatic efficiency of the
D-12 cells (Figure 7). The metastatic efficiency in untreated mice
was higher than that in antibody-treated mice by a factor of 2–3 for
aerobic control cultures (P < 0.05) and by a factor of 5–6 for cell
cultures exposed to hypoxia for 24 h and assayed immediately
after the reoxygenation (P < 0.001). Hypoxia-treated cultures
showed a higher metastatic efficiency than aerobic control cultures
in untreated mice (P < 0.05), consistent with the data in Figure 1.
In contrast, the metastatic efficiency of hypoxia-treated cultures
was not significantly different from that of aerobic control cultures
in antibody-treated mice (P > 0.05). Also the A-07 cells showed
reduced metastatic efficiency in mice treated with neutralizing
antibody against VEGF (Figure 7). The metastatic efficiency in
untreated mice was higher than that in antibody-treated mice by a
factor of 2–3 for both aerobic control cultures (P < 0.05) and
cultures assayed immediately after a hypoxia treatment of 24 h
(P < 0.05). Aerobic control cultures and hypoxia-treated cultures
showed metastatic efficiencies that were not significantly
different, either in untreated mice (P > 0.05) or in antibody-treated
mice (P > 0.05).
Treatment of host mice with neutralizing antibody against
VEGF also resulted in a decrease in the angiogenic potential of the
A-07 and D-12 cells (Figure 8). The angiogenic potential of
aerobic cell cultures was higher in untreated mice than in anti-
body-treated mice by a factor of approximately 1.5 for both A-07
(P < 0.001) and D-12 (P < 0.01).
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Figure 7 A-07 (A) and D-12 (B) cells harvested from aerobic control cultures or cultures exposed to hypoxia in vitro for 24 h were inoculated intravenously in
female BALB/c-nu/nu mice for formation of lung colonies. The hypoxia-treated cells were inoculated immediately (< 1 h) after the reoxygenation. The lung
colonies were scored 5 weeks after the inoculation. The plots show number of lung colonies per 1.0 ´ 106 viable A-07 cells or per 1.0 ´ 105 viable D-12 cells.
Filled columns refer to cells inoculated in untreated mice and open columns to cells inoculated in mice treated with neutralizing antibody against VEGF. Mean
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Figure 8 A-07 and D-12 cells harvested from aerobic cell cultures were
inoculated intradermally in female BALB/c-nu/nu mice for angiogenesis
evocation and tumour formation. Angiogenesis was quantified by counting
the capillaries in the dermis oriented towards the tumours at day 5 (A-07) or
day 7 (D-12) after the inoculation. The plot shows number of tumour-oriented
capillaries after inoculation of 1.0 ´ 106 cells. Filled columns refer to cells
inoculated in untreated mice and open columns to cells inoculated in mice
treated with neutralizing antibody against VEGF. Mean values (columns) and
s.e.m. (bars) of 20 tumoursDISCUSSION
Experimental studies of relationships between tumour metastasis,
angiogenesis and concentrations of specific angiogenic factors
require the use of adequate tumour models. Two human melanoma
lines giving rise to pulmonary metastases in athymic nude mice
were used as models in the study reported here. These lines are
useful models for studies of molecular mechanisms involved in
hypoxia-induced changes in metastatic propensity for several
reasons. Thus, both cell lines form distinct, well-defined and hence
easily scorable lung colonies following intravenous cell inocula-
tion, and there is a linear relationship between the number of lung
colonies and the number of inoculated cells in both lines.
Moreover, the difference in metastatic efficiency between the lines
is not a result of a difference in intrinsic metastatic propensity, but
is rather a result of different host immune reactivities against the
lines (Rofstad, 1995).
The study reported here has shown that the metastatic efficiency
of human tumour cells can be enhanced by hypoxia. Thus, D-12
cell cultures exposed to hypoxia in vitro, reoxygenated and inocu-
lated i.v. in athymic nude mice showed increased lung coloniza-
tion efficiency relative to aerobic control cultures. However,
hypoxia does not necessarily increase the metastatic efficiency
of the cells of all tumours; the lung colonization efficiency of the
A-07 cells was not enhanced by hypoxia treatment in vitro. Young
et al (1988) have reported previously that exposure to hypoxia in
vitro can increase the lung colonization efficiency of murine
tumour cells (KHT-C2-LP1 fibrosarcoma and B16F10-A1
melanoma) and attributed the effect to hypoxia-induced DNA-
overreplication and unspecific gene amplification. No overall
temporal correlation between the increase in lung colonization
efficiency following exposure to hypoxia and hypoxia-induced
changes in the m-RNA levels for cathepsin B, cathepsin L, nm23,
TIMP-1, osteopontin or VEGF was found for these murine tumour
cells (Jang and Hill, 1997).
The mechanism of the hypoxia-induced increase in metastatic
efficiency in the D-12 cells was probably fundamentally different
from that in the murine tumour cells studied by Young et al (1988).
Firstly, the kinetics as well as the magnitude of the effect differed
significantly between the D-12 and the murine tumour cells. When
the murine tumour cells were exposed to hypoxia for 18–24 h, the
metastatic efficiency was reduced slightly immediately after the
reoxygenation, increased with the reoxygenation time, reached a
maximum at about 18 h after the reoxygenation and then decayed
with the reoxygenation time. In contrast, the metastatic efficiency
of the D-12 cells was highest immediately after the reoxygenation,
decreased with the reoxygenation time and was similar to that of
aerobic control cultures at about 24 h after the reoxygenation.
At maximum, the metastatic efficiency was enhanced by a factor
of 6–14 in the murine tumour cells and by a factor of only 3–4
in the D-12 cells. Secondly, in contrast to the murine tumour cells,
the D-12 cells did probably not show unspecific gene amplifica-
tion following exposure to hypoxia, as DNA-overreplication
similar to that observed by Young et al (1988) in the studies of the
murine KHT-C2-LP1 fibrosarcoma and B16F10-A1 melanoma
cells could not be detected when D-12 cells were subjected to flow
cytometric analyses.
The D-12 cells increased slightly in volume during prolonged
(> 8 h) exposure to hypoxia. Increased cell volume might promote
the formation of metastases by facilitating the arrest of tumour
cells in the microcirculation. Prolonged hypoxia treatment also
resulted in inactivation of a significant fraction of the D-12 cells.
Since cell inactivation by hypoxia can be cell cycle-dependent
(Spiro et al, 1984), the cell cycle distribution of the non-
inactivated D-12 cells might have differed from that of the aerobic
control cells. The lung colonization ability of cells can depend on
their position in the cell cycle (Suzuki et al, 1977). However, it is
unlikely that the hypoxia-induced increase in metastatic efficiency
in the D-12 cells can be attributed to hypoxia-induced alterations
in cell volume or cell cycle distribution. The hypoxia-induced
alterations in cell volume and PE were similar in the D-12 and the
A-07 cells, and the A-07 cells did not show increased metastatic
efficiency following exposure to hypoxia. Moreover, the
metastatic efficiency of the D-12 cells was enhanced by a factor of
2–3 immediately after a hypoxia treatment of 4–8 h, and a hypoxia
treatment of 4–8 h did not cause significant alterations in cell
volume or PE.
The hypoxia-induced increase in metastatic efficiency in the
D-12 cells was rather a result of a hypoxia-induced increase
in angiogenic potential. Thus, the D-12 cells, which showed
hypoxia-induced metastasis, evoked increased angiogenesis
following exposure to hypoxia, whereas the A-07 cells, which did
not show hypoxia-induced metastasis, did not. Moreover, tumour
transplantability, which also is angiogenesis-dependent, was
enhanced following hypoxia treatment in the D-12 cells but not
in the A-07 cells. Finally, the kinetics of the hypoxia-induced
increases in metastasis and transplantability were similar to that of
the hypoxia-induced increase in angiogenic potential.
VEGF was probably involved in the hypoxia-induced angiogen-
esis causing the enhanced metastatic efficiency of hypoxia-treated
D-12 cells. Thus, non-glycosylated VEGF165 and VEGF121 were
clearly up-regulated in cell cultures exposed to hypoxia for about
4 h and 24 h respectively. The rate of VEGF secretion in vitro was
higher under hypoxic conditions than under aerobic conditions by
a factor of approximately 7. Moreover, the metastatic efficiency
and the angiogenic potential of the D-12 cells were reduced
significantly in mice treated with neutralizing antibody against
VEGF. Hypoxia-treated and aerobic control cultures showed
similar metastatic efficiencies in antibody-treated mice. However,
the present study does of course not exclude the possibility that
angiogenic factors other than VEGF also were involved in the
hypoxia-induced increases in metastatic efficiency and angiogenic
potential in the D-12 cells.
The neovascularization and expansion of micrometastases do
not occur until several days after their establishment. Northern blot
analyses have shown that hypoxia-induced VEGF up-regulation in
vitro decreases with the time after reoxygenation with a half-life of
a few hours (Shweiki et al, 1992; Hlatky et al, 1994), consistent
with the observation that a reoxygenation time of 24 h, but not a
reoxygenation time of 4 h, was sufficient to eliminate the hypoxia-
induced increase in metastatic efficiency in the D-12 cells.
Consequently, the later phases of the angiogenic process were
probably not influenced significantly by exposing the D-12 cells to
hypoxia. It is predominantly more likely that VEGF contributed
to the hypoxia-induced increase in the metastatic efficiency of the
D-12 cells by potentiating the initial phase of angiogenesis, i.e. by
stimulating the expression of endothelial cell proteases and hence
the degradation of the basement membrane (Unemori et al, 1992;
Mandriota et al, 1995).
Perhaps more importantly, VEGF may have contributed signifi-
cantly to the increased metastatic efficiency of hypoxia-treated
D-12 cells by a mechanism which is only partly related to the
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ability factor based on its ability to induce vascular leakage in
several organs, including skin and peritoneal wall (Senger et al,
1983; Dvorak, 1986; Nagy et al, 1995). VEGF increases micro-
vascular permeability through activation of vesicular-vacuolar
organelles in endothelial cells (Feng et al, 1996) and through the
induction of inter-endothelial cell gaps and endothelial fenestration
(Roberts and Palade, 1995). The vascular permeabilizing effect
occurs rapidly, becoming evident within several minutes after
VEGF exposure (Dvorak et al, 1979; Senger et al, 1983; Nagy et al,
1995). VEGF may therefore have increased the metastatic efficiency
of hypoxia-treated D-12 cells by facilitating cell extravasation into
the lungs. Moreover, increased microvascular permeability is prob-
ably also a crucial step in tumour angiogenesis, as Dvorak (1986)
has presented evidence that a major function of VEGF in the angio-
genic process is the induction of plasma protein leakage, an effect
which results in the formation of an extravascular fibrin gel serving
as a substrate for endothelial and tumour cell growth. Consequently,
the vascular permeabilization effect of VEGF may have contributed
to the hypoxia-induced increase in the metastatic efficiency of the
D-12 cells not only by assisting cell extravasation, but also by poten-
tiating tumour angiogenesis after the extravasation. Thus, this inter-
pretation of the metastasis data is consistent with the observation
that the transplantability of the D-12 cells was increased by expo-
sure to hypoxia.
Also the A-07 cells showed VEGF upregulation under hypoxic
conditions in vitro, but these cells, in contrast to the D-12 cells, did
not show hypoxia-induced metastasis and angiogenesis. Several
observations suggest that the lack of hypoxia-induced metastasis
and angiogenesis in the A-07 cells was not due to the VEGF of these
cells being inactive in vivo. Thus, the metastatic efficiency and the
angiogenic potential of the A-07 cells were reduced significantly in
mice treated with neutralizing antibody against VEGF, similar to
what was seen for the D-12 cells. Moreover, ten of ten mice have
been found to develop ascitic fluid following intraperitoneal
(i.p.) inoculation of 1.0 ´ 106 A-07 cells, whereas i.p.
inoculation of 1.0 ´ 106 D-12 cells resulted in the development of
ascites in only one of ten mice (unpublished data). Similar studies of
human ovarian carcinomas in athymic nude mice have shown that
the production of ascites is directly associated with the expression of
active VEGF (Yoneda et al, 1998). Finally, the Western blot analyses
suggested that the same isoforms of VEGF were expressed by A-07
and D-12 cells, both under aerobic and hypoxic conditions.
The lack of hypoxia-induced metastasis and angiogenesis in the
A-07 cells was probably rather a consequence of the high expres-
sion of VEGF under aerobic conditions; the aerobic rate of VEGF
secretion was higher in the A-07 cells than in the D-12 cells by a
factor of approximately 40. It is therefore possible that VEGF was
a limiting factor for the development of metastases and the rate of
angiogenesis in the D-12 cells but not in the A-07 cells. If so,
exposure of the A-07 cells to hypoxia just led to increased secre-
tion of redundant VEGF.
The present study has significant influence on our under-
standing of the role of VEGF in the angiogenesis of malignant
melanoma. If the data presented here are representative for
melanomas in man, three important conclusions may be derived.
Firstly, melanomas in different patients can differ substantially in
VEGF expression. Secondly, VEGF may be a limiting factor for
the rate of angiogenesis in low VEGF-expressing melanomas but
not in high VEGF-expressing melanomas under normoxic condi-
tions. Thirdly, the VEGF expression in low VEGF-expressing
melanomas may be up-regulated by hypoxia to an extent sufficient
to increase the rate of angiogenesis. Consequently, the rate of
VEGF secretion might be an important determinant of the rate of
angiogenesis in malignant melanoma. This suggestion is consis-
tent with the observation that human melanoma xenografts trans-
fected with VEGF can show increased vascular density relative
to non-transfected control tumours (Claffey et al, 1996; Pötgens
et al, 1996).
Our understanding of the mechanisms governing the develop-
ment of metastases in malignant melanoma is also influenced
significantly by the present study. Melanomas gradually develop
aggressive phenotypic traits with time, including invasive growth
and metastatic spread (Herlyn, 1990), a property they have in
common with several histological types of cancer (Foulds, 1975).
This process is termed malignant progression and has been
suggested to be a result of genomic instability (Hill, 1990).
Evidence has been presented that tumour hypoxia followed by
reoxygenation might increase the genomic instability of tumours
and hence promote the formation of metastatic cell phenotypes
(Hill, 1990; Brown and Giaccia, 1994; Dachs and Stratford, 1996).
The study reported here suggests an additional mechanism by
which acute hypoxia might promote the development of metas-
tases in melanoma. Melanoma cells intravasating from tumour
regions subjected to transient stoppages in microregional blood
flow might show up-regulated VEGF expression and hence have
elevated capacity to extravasate, induce neovascularization and
give rise to macroscopic metastatic growth when trapped in the
capillary bed of a distant organ such as the lungs. It should be
noted that our data suggest that this mechanism of hypoxia-
induced metastasis applies only to melanomas showing low VEGF
expression under normoxic conditions and that the increased
metastatic efficiency induced during hypoxia is a transient
phenomenon; the metastatic efficiency might be significantly
elevated at least until 4 h after the reoxygenation, but probably not
until 24 h after the reoxygenation.
The mechanism of hypoxia-induced metastasis suggested here
is consistent with data from clinical studies involving soft tissue
sarcoma, cervix carcinoma and carcinoma of the head and neck
showing that primary tumours with low oxygen tensions or high
lactate concentrations metastasize more frequently than primary
tumours with high oxygen tensions or low lactate concentrations
(Schwickert et al, 1995; Brizel et al, 1996; Höckel et al, 1996;
Walenta et al, 1997; Sundfør et al, 1998). It is also consistent with
observations showing that the probability of metastasis in many
tumour types is positively correlated to the vascular density in
vascular ‘hot spots’ of the primary tumour, as vascular ‘hot spots’
might result from hypoxia-induced angiogenesis mediated by
VEGF (Weidner, 1993).
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